本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Avadel Pharmaceuticals plc

22.95
-0.6100-2.59%
成交量:303.30万
成交额:6,992.86万
市值:22.41亿
市盈率:-7,985.39
高:23.36
开:23.25
低:22.86
收:23.56
52周最高:23.57
52周最低:6.38
股本:9,765.67万
流通股本:8,064.30万
量比:0.84
换手率:3.76%
股息:- -
股息率:- -
每股收益(TTM):-0.0029
每股收益(LYR):-0.5133
净资产收益率:-0.32%
总资产收益率:-0.34%
市净率:22.82
市盈率(LYR):-44.71

数据加载中...

2022/04/26

重要事件披露

8-K - Current report
2022/04/15

重要事件披露

8-K - Current report
2022/04/07

重要事件披露

8-K/A [Amend] - Current report
2022/04/05

重要事件披露

8-K - Current report
2022/03/17

重要事件披露

8-K - Current report
2022/03/16

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/16

重要事件披露

8-K - Current report
2022/03/16

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/11

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/21

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/17

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/09

重要事件披露

8-K - Current report
2021/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]